nafronyl has been researched along with Respiratory Insufficiency in 2 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Respiratory Insufficiency: Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, SA | 1 |
| Pace, JE | 1 |
| Cox, ML | 1 |
| Matschke, RG | 1 |
2 other studies available for nafronyl and Respiratory Insufficiency
| Article | Year |
|---|---|
Respiratory distress secondary to naftidrofuryl.
Topics: Aged; Aged, 80 and over; Capsules; Humans; Male; Mastication; Nafronyl; Respiratory Insufficiency | 1990 |
[Allergic reaction in therapy with naftidrofuryl (Dusodril). A case report].
Topics: Administration, Oral; Adult; Drug Hypersensitivity; Female; Furans; Hearing Loss; Hearing Loss, Cond | 1987 |